Cipla celebrates 90 years with focus on quality products, global presence, and investment in research and technology.

Mumbai-headquartered drugmaker Cipla Ltd is bolstering its focus on a pipeline of drugs to fight infections caused by ...

Shanghai: Indian pharmaceutical giant Cipla is exploring entry into at least two new international markets for products manufactured at its factory in Jiangsu province, China, as part of a ...

Common flu, seasonal throat infections, and fevers are on the rise in India, making it imperative to practice every day self-care and community protection. Leading the charge, Cipla Health Ltd., one ...

The healthcare sector, particularly pharmaceuticals and hospitals, have demonstrated strong performance in the March 2025 quarter, with revenue growth exceeding that of Nifty 500 companies. Even ...

Shift is expected to drive a sharp increase in generic drug launches, positioning Indian drugmakers for strong growth ...

Linda Jónsdóttir, Alvotech's Chief Financial Officer ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the expansion of its capacity for ...

The Business Research Company's Asthma and COPD Drugs Market 2025: Strategic Insights for Growth, Expansion, and Gaining Competitive Edge It will grow to $50.99 billion in 2029 at a compound annual ...

Alvotech and Advanz Pharma have previously entered into partnership agreements for biosimilar candidates to more than ten reference biologics. The companies expect to launch their first biosimilars in ...